%0 Journal Article %T 前蛋白转化酶枯草溶菌素 9 单克隆抗体治疗冠状动脉粥样硬化性心脏病的临床研究进展<br>Clinical advances in monoclonal antibody against PCSK9 for coronary atherosclerotic heart disease %A 罗聪聪 %A 鲍春荣 %A 何斌 < %A br> %A LUO Cong-cong %A BAO Chun-rong %A HE Bin %J 上海交通大学学报(医学版) %D 2018 %R 10.3969/j.issn.1674-8115.2018.03.018 %X 冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease,CHD)的发病率及病死率居全球首位,而低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)的升高是 CHD 的主要危险因素,因此降低 LDL-C 水平可有效减少 CHD 的发病风险。临床上降脂药物如他汀类虽能够有效降低 LDL-C 水平,但仍有部分患者无法达到降脂目标或者无法耐受。前蛋白转化酶枯草溶菌素 9(proprotein convertase subtilisin/kexin type 9,PCSK9)抑制剂作为新一代的降脂药物,越来越受到重视。其通过对 PCSK9 的抑制作用,增加低密度脂蛋白受体的循环利用,能够显著降低血清中 LDL-C 水平。目前 PCSK9 抑制剂已进入Ⅲ期临床试验,试验结果显示其具有良好的降脂效果和耐受性。该文就 PCSK9 抑制剂最新进展和面临的问题作一综述。<br>:Coronary atherosclerotic heart disease (CHD) remains the leading cause of morbidity and mortality in the world, with elevated low density lipoprotein-cholesterol (LDL-C) levels as a major risk factor. Lower levels of LDL-C can effectively reduce the risk of CHD. To date, lipid-lowering medicines such as statins are effective in lowering LDL-C, but a proportion of patients do not achieve lipid reduction target with statins or are intolerant to statins. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of agents reducing LDL-C which gain more and more concerns. Through inhibitory effect on PCSK9 and increasing low-density lipoprotein receptors recycling, they can significantly reduce serum LDL-C levels. PCSK9 inhibitors are currently in phase Ⅲ of clinical trials, and the results showed that they had good lipid-lowering effects and tolerability. This review provided an overview of the latest advances and challenges about PCSK9 inhibitors %K &ensp %K 前蛋白转化酶枯草溶菌素 9 %K 抑制剂 %K 单克隆抗体 %K 低密度脂蛋白胆固醇 %K 冠状动脉粥样硬化性心脏病 %K 高脂血症 %K < %K br> %K proprotein convertase subtilisin/kexin type 9 (PCSK9) %K inhibitor %K monoclonal antibody %K low-density lipoprotein-cholesterol (LDL-C) %K coronary atherosclerotic heart disease (CHD) %K hyperlipidemia %U http://xuebao.shsmu.edu.cn/CN/abstract/abstract11848.shtml